首页 | 本学科首页   官方微博 | 高级检索  
检索        

脐血CD3AK细胞治疗难治性恶性淋巴瘤的临床研究
引用本文:苏毅,赵碧,赵越华,邵文军,郑华金.脐血CD3AK细胞治疗难治性恶性淋巴瘤的临床研究[J].西南国防医药,2001,11(2):91-92.
作者姓名:苏毅  赵碧  赵越华  邵文军  郑华金
作者单位:成都军区总医院血液科
摘    要:目的:探讨脐血CD3AK细胞对难治性恶性淋巴瘤的治疗作用。方法:分离脐血单个核细胞,采用Anti-CD3McAb和rⅡ-2C EY YTETG CD3AK细胞。运动MTT法测定CD3AK细胞的杀瘤活性,并采用静脉输注和瘤体内注射治疗难治性恶性淋巴瘤15例。结果:脐血单个核细胞诱生的CD3AK细胞在体外对K562和Raji细胞有明显杀伤作用,治疗15例难治性恶性淋巴瘤,完全缓解4例,部分缓解2例,有效率40%,结论:脐血CD3AK细胞绎难治性淋巴瘤具有较好疗效。

关 键 词:CD3AK细胞  脐血  恶性淋巴瘤  治疗
修稿时间:2000年10月21

CLINICAL EFFECTS OF CD3AK CELLS DERIVED FROM CORD BLOOD ON REFRACTORY LY MPHOMA
Su Yi,Zhao Bi,Zhao Yuehua,Shao Wenjun,Zheng Huajin.CLINICAL EFFECTS OF CD3AK CELLS DERIVED FROM CORD BLOOD ON REFRACTORY LY MPHOMA[J].Medical Journal of National Defending forces in Southwest China,2001,11(2):91-92.
Authors:Su Yi  Zhao Bi  Zhao Yuehua  Shao Wenjun  Zheng Huajin
Institution:Su Yi,Zhao Bi,Zhao Yuehua,Shao Wenjun,Zheng HuajinDepartment of Hematology,General Hospital of Chengdu Military Command,Chengdu,610083
Abstract:Objective To study the clinical effects of CD3 AK cells on refractory lymphoma. Method CD3 AK cells were prepared with monocytes separated from cord blood and then induced by anti - CD3 McAb, rIL - 2 and PHA. The activity of CD3 AK cells was measured with MTT method. Result K562 and Raji cell were killed significantly by CD3 AK cells in vitro. 4 of 15 patients treated with CD3 AK cells alleviated completely and 2 alleviated partially. The total effective rate was 40% . Conclusion: CD3 AK cells derived from cord blood are hopeful to the treatment of refractory lymphoma.
Keywords:CD_3 AK cell  cord blood  lymphoma  treatment
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号